FDA approves Vera Therapeutics’ Trutakna for autoimmune kidney disease IgA nephropathy
The FDA approved Vera Therapeutics' drug Trutakna to treat IgA nephropathy, a chronic autoimmune kidney disease that can progress to kidney failure, marking a milestone for Vera and advancing biotech options for patients.